We are excited to have Dr. William H. Isacoff return to our Patient & Family Webinar series with a follow-up to his previous webinar Chemotherapy for Pancreatic Cancer Patients: Less is More! Dr. Isacoff is a fan-favorite and we are happy to have him share, once again, with our community.
Dr. William H. Isacoff, who leads the Pancreatic Cancer Center of Los Angeles, has earned a reputation as one of the foremost gastrointestinal oncologists within the United States. He has developed treatment regimens which were not only more effective, but less toxic and extended the lives of pancreatic patients throughout the country. He continues to focus on the development of newer, more effective and less toxic treatments for patients with pancreatic cancer.
In July of 2020, Dr. Isacoff shared important information about his low dosage “metronomic” chemotherapy without radiation therapy. Dr. Isacoff and the Pancreatic Surgical Team at UCLA have down staged more than 60 patients who upon initial diagnosis were felt to be inoperable. After successful “metronomic” treatment with a combination of chemotherapies, the patients were then able to become surgical candidates. In addition, as a result of the prolonged use of effective chemotherapy, 75% of the patients had lymph nodes that did not show metastatic disease. Dr. Isacoff shared these promising results and looks forward to continuing the conversation with his latest presentation.
William H. Isacoff, M.D., currently holds an academic appointment within the Department of Medicine at the David Geffen-UCLA School of Medicine. He serves on the Board of Directors of the Jonsson Comprehensive Cancer Foundation. He serves on the International Board of Governors of the Hebrew University of Jerusalem, and is a lifetime trustee of that university. He has designed clinical trials for and served as a consultant. He has worked for four decades to form better, safer and more effective treatments for patients battling pancreatic cancer and other gastrointestinal cancers.